China’s population size, large clinical infrastructure, growing demand for health products, and limited regulatory environment have led China to become the world’s largest experimental site for clinical trials and pharmaceutical market. Based in PUMC’s Bioethics Center, this project proposes to fill in the cognitive, moral and regulatory gaps in bioethics and strengthen capacity of researchers, ethical committee members, faculty, biomedical editors and policy makers through workshops, symposiums and exchange programs. It will provide 120 stakeholders with bioethics training through three workshops, and train another 120 potential trainers through three international symposiums. The Center will send six graduate students and 2 key faculties to the University of Pennsylvania and NIH for 6-12 month trainings. The Center has been deeply involved in developing national guidelines and regulations as related to bioethics and will continue to engage actively to assist policy making.